| |
| |
|
| Insider
Information: |
Henderson Molly |
| Relationship: |
|
| City: |
Rochester |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
112,784 |
|
|
Indirect Shares
|
1,911 |
|
|
| Direct
Value |
$75,933 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
114,695 |
|
|
| Total
Value |
$75,933 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
1.0
|
| Percentage
Gain/Loss : |
 -54.1%
|
 37.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Virtualscopics, Inc. |
VSCP |
CFO |
2008-03-14 |
6,440 |
2008-03-14 |
0 |
Premium* |
|
|
Advaxis Inc |
ADXS |
Executive Vice Preside... |
2019-04-11 |
5,833 |
2018-06-12 |
0 |
Premium* |
|
|
Urogen Pharma Ltd. |
URGN |
Chief Financial Officer |
2022-01-31 |
5,248 |
2021-05-17 |
0 |
Premium* |
|
|
Phathom Pharmaceuticals, Inc. |
PHAT |
|
2024-04-08 |
95,263 |
2024-04-08 |
1,911 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2024-04-08 |
4 |
S |
$11.10 |
$38,129 |
D/D |
(3,435) |
95,263 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2024-01-19 |
4 |
S |
$7.75 |
$48,900 |
D/D |
(6,307) |
98,698 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2023-11-20 |
4 |
S |
$7.24 |
$15,403 |
D/D |
(2,127) |
103,061 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2023-07-14 |
4 |
A |
$1.00 |
$25,000 |
D/D |
25,000 |
95,180 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2023-06-02 |
4 |
AS |
$11.41 |
$22,368 |
D/D |
(1,960) |
68,506 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2023-05-22 |
4 |
AS |
$12.87 |
$27,165 |
D/D |
(2,110) |
70,466 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2023-04-06 |
4 |
AS |
$7.27 |
$25,002 |
D/D |
(3,439) |
72,576 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2023-03-01 |
4 |
AS |
$8.53 |
$17,335 |
D/D |
(2,032) |
76,015 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
78,047 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2022-11-21 |
4 |
S |
$9.60 |
$20,726 |
D/D |
(2,159) |
43,341 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2022-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
45,500 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
38,000 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2022-05-13 |
4 |
B |
$0.00 |
$0 |
D/D |
6,000 |
26,000 |
2.66 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
CFO and CBO |
• – – |
2022-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Financial Officer |
• – – |
2022-01-31 |
4 |
S |
$7.58 |
$2,509 |
D/D |
(331) |
5,248 |
0 |
% |
|
| URGN |
Urogen Pharma Ltd. |
Chief Financial Officer |
• – – |
2022-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
666 |
5,579 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Financial Officer |
• – – |
2021-05-17 |
4 |
B |
$15.85 |
$39,625 |
D/D |
2,500 |
2,500 |
2.74 |
% |
|
| ADXS |
Advaxis Inc |
Executive Vice President & CFO |
• – – |
2019-04-11 |
4 |
A |
$3.68 |
$9,200 |
D/D |
2,500 |
5,833 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Executive Vice President & CFO |
• – – |
2019-04-09 |
4 |
A |
$3.85 |
$11,579 |
D/D |
3,000 |
100 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Executive Vice President & CFO |
• – – |
2018-06-12 |
4 |
A |
$1.89 |
$9,450 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| VSCP |
Virtualscopics, Inc. |
CFO |
• – – |
2008-03-14 |
4 |
B |
$0.68 |
$4,379 |
D/D |
6,440 |
6,440 |
2.66 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
